Is the Options Market Predicting a Spike in Haemonetics Stock?

Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut

Haemonetics Q4 Earnings Call Highlights

The London Company Small Cap Portfolio Q1 2026 Portfolio Review

Haemonetics Corporation (HAE) Q4 2026 Earnings Call Transcript

Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say

Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates

Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Haemonetics to Present at Bank of America 2026 Healthcare Conference

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Analyzing Bio-Rad Laboratories (NYSE:BIO) & Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) vs. Guided Therapeutics (OTCMKTS:GTHP) Head to Head Review

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

Here's Why Haemonetics (HAE) is a Strong Value Stock

Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term

Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?

Elo Mutual Pension Insurance Co Takes $829,000 Position in Haemonetics Corporation $HAE

Allspring Special Small Cap Value Fund Q4 2025 Portfolio Review

Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026

Here's Why Haemonetics (HAE) is a Strong Value Stock

Touchstone Small Cap Fund Q4 2025 Portfolio Review

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline

The London Company Small Cap  Q4 2025 Performance And Trades

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting

Haemonetics (HAE) International Revenue Performance Explored

Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Haemonetics Q3 Earnings Call Highlights

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Haemonetics (HAE) is a Top-Ranked Growth Stock: Should You Buy?

Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips

Haemonetics Corporation (HAE) Q3 2026 Earnings Call Transcript

Intellia Therapeutics: 2 Major Catalysts Will Determine Stock's Trajectory In 2026

Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say

Haemonetics (HAE) Q3 Earnings and Revenues Beat Estimates

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Allspring Common Stock Fund Q4 2025 Performance Review

Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?

DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE)

Is it Apt to Retain HAE Stock in Your Portfolio for Now?

Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Here's Why Haemonetics (HAE) is a Strong Growth Stock

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics